CD45 CELL-SURFACE ANTIGENS ARE LINKED TO STIMULATION OF EARLY HUMAN MYELOID PROGENITOR CELLS BY INTERLEUKIN-3 (IL-3), GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF), A GM-CSF IL-3 FUSION PROTEIN, AND MAST-CELL GROWTH-FACTOR (A C-KIT LIGAND)

被引:32
作者
BROXMEYER, HE
LU, L
HANGOC, G
COOPER, S
HENDRIE, PC
LEDBETTER, JA
XIAO, M
WILLIAMS, DE
SHEN, FW
机构
[1] INDIANA UNIV, SCH MED, DEPT MED HEMATOL ONCOL, INDIANAPOLIS, IN 46202 USA
[2] INDIANA UNIV, SCH MED, DEPT MICROBIOL & IMMUNOL, INDIANAPOLIS, IN 46202 USA
[3] ONCOGEN BRISTOL MYERS SQUIBB, SEATTLE, WA 98121 USA
[4] IMMUNEX CORP, DEPT EXPTL HEMATOL, SEATTLE, WA 98101 USA
[5] TAMPA BAY RES INST, MAMMALIAN IMMUNOGENET LAB, TAMPA BAY, FL 33716 USA
关键词
D O I
10.1084/jem.174.2.447
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD45 antigens are protein tyrosine phosphatases. A possible link was evaluated between expression of CD45 antigens on human myeloid progenitor cells (MPC) (colony-forming unit-granulocyte/macrophage [CFU-GM], burst-forming unit-erythroid [BFU-E], and colony-forming unit-granulocyte/erythroid/macrophage/megakaryocyte [CFU-GEMM]) and regulation of MPC by colony-stimulating factors (CSF) (interleukin 3 [IL-31, GM-CSF, G-CSF, M-CSF, and erythropoietin [Epo]), a GM-CSF/IL-3 fusion protein, and mast cell growth factor (MGF; a c-kit ligand). Treatment of cells with antisense oligodeoxynucleotides (oligos) to exons 1 and 2, but not 4, 5, or 6, of the CD45 gene, or with monoclonal anti-CD45, significantly decreased CFU-GM colony formation stimulated with GM-CSF, IL-3, a GM-CSF/IL-3 fusion protein, and GM-CSF + MGF, but not with G-CSF or M-CSF. It also decreased GM-CSF, IL-3, fusion protein, and MGF-enhanced Epo-dependent BFU-E and CFU-GEMM colony formation, but had little or no effect on BFU-E or CFU-GEMM colony formation stimulated by Epo alone. Similar results were obtained with unseparated or purified (greater than or equal to one of two cells being a MPC) bone marrow cells. Sorted populations of CD34(3+) HLA-DR+ marrow cells composed of 90% MPC were used to demonstrate capping of CD45 after crosslinking protocols. Also, a decreased percent of CD45+ cells and CD45 antigen density was noted after treatment of column-separated CD34+ cells with antisense oligos to exon 1 of the CD45 gene. These results demonstrate that CD45 cell surface antigens are linked to stimulation of early human MPC by IL-3, GM-CSF, a GM-CSF/IL-3 fusion protein, and MGF.
引用
收藏
页码:447 / 458
页数:12
相关论文
共 43 条
[1]  
BERENSON RJ, 1991, BLOOD, V77, P1717
[2]  
BROXMEYER HE, 1990, BLOOD, V76, P1110
[3]   COLONY ASSAYS OF HEMATOPOIETIC PROGENITOR CELLS AND CORRELATIONS TO CLINICAL SITUATIONS [J].
BROXMEYER, HE .
CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1984, 1 (03) :227-257
[4]   THE PRODUCTION OF MYELOID BLOOD-CELLS AND THEIR REGULATION DURING HEALTH AND DISEASE [J].
BROXMEYER, HE ;
WILLIAMS, DE .
CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1988, 8 (03) :173-226
[5]  
BROXMEYER HE, 1990, BLOOD, V76, P323
[6]  
BROXMEYER HE, 1985, PROG ALLERGY, V36, P202
[7]  
BROXMEYER HE, 1991, EXP HEMATOL, V19, P143
[8]  
BROXMEYER HE, 1991, BLOOD, V77, P2142
[9]   THE LEUKOCYTE COMMON ANTIGEN (CD45) - A PUTATIVE RECEPTOR-LINKED PROTEIN TYROSINE PHOSPHATASE [J].
CHARBONNEAU, H ;
TONKS, NK ;
WALSH, KA ;
FISCHER, EH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (19) :7182-7186
[10]  
CURTIS BM, 1991, IN PRESS P NATL ACAD